Identity
- Trade Name
- Sherlock FDA UDI
- Generic Name
- Patient positioning sensor FDA UDI
- Device Name
- SHERLOCK 3CG TCS SENSOR FDA UDI
- Model / Reference
- 9770131 FDA UDI
- Description
- SHERLOCK 3CG TCS SENSOR FDA UDI
Identifiers
- Catalog Number
- 9770131 FDA UDI
- Primary DI / UDI-DI
- 00801741124341 FDA UDI
- FDA Product Code
- LJS FDA UDI
- GMDN Term
- Patient positioning sensor FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 880.5970 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Patient positioning sensor
Sherlock by Bard Access Systems, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Patient positioning sensor.
- NGENIUS — Stryker Leibinger · Class II
- EV1000 — Edwards Lifesciences LLC · Class II
- V40 — MAKO Surgical Corp. · Class II
- Patient tracker EM-D mini — Scopis GmbH · Class II
- General Purpose Sensor — CIVCO MEDICAL INSTRUMENTS CO., INC. · Class II
- Calibration End Effector Inverted — MAKO Surgical Corp. · Class II
- Patient tracker EM mini — Scopis GmbH · Class II
- EnSite™ — ST. JUDE MEDICAL, INC. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bard Access Systems, Inc.
Sources (1)
- FDA UDI 4082ed40-7006-4bea-be51-3a6864352ec8 36 fields · synced Jun 9, 2026